NOVI, Mich., Aug. 27, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI), a global leader of safe, in

Stoneridge (NYSE: SRI) reported second-quarter 2026 results that exceeded its internal expectations,

New high-performance ECU designed to simplify vehicle architecture and enable software-defined capab

Stoneridge NYSE: SRI reported second-quarter 2026 results that exceeded its internal expectations, s

Stoneridge, Inc. (SRI) Q2 2026 Earnings Call Transcript

Stoneridge (SRI) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estima

Stoneridge (NYSE:SRI) reported quarterly losses of $(0.18) per share which missed the analyst consen

Stoneridge (NYSE:SRI) affirms FY2026 sales outlook from $645.000 million-$670.000 million to $645.00

Strengthening Demand & Expense Control Underpin 2Q Performance NOVI, Mich., Aug. 5, 2026 /PRNewswire

NOVI, Mich., July 27, 2026 /PRNewswire/ -- Stoneridge, Inc. today announced a major new program awar

Stoneridge, Inc. (NYSE: SRI - Get Free Report)'s share price passed above its 200-day moving average

NOVI, Mich., July 22, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) will release second quarter

Stoneridge, Inc. (NYSE:SRI), a leading supplier of safe, intelligent and efficient electronic techno

NOVI, Mich., June 30, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI), a leading supplier of safe,

Debut of new ECU technology that enables unified, software-defined vehicle architecture Showcase of

TORONTO, ON / ACCESS Newswire / June 18, 2026 / Sparton Resources Inc. (TSXV:SRI) ("Sparton" or the

JPMorganChase today announced the expansion of its $1.5 trillion, 10-year [url="]Security and Resili

NEW YORK--(BUSINESS WIRE)--JPMorganChase today announced the expansion of its $1.5 trillion, 10-year

LONDON--(BUSINESS WIRE)--Ellipses Pharma (“Ellipses”), a global oncology drug development company wi

Stoneridge, Inc. (SRI) Q1 2026 Earnings Call Transcript

Stoneridge (NYSE:SRI) raises FY2026 sales outlook from $625.000 million-$650.000 million to $645.000

Stoneridge (NYSE:SRI) reported quarterly losses of $(0.75) per share which missed the analyst consen

Q1 Performance Demonstrates Solid Progress Continued Strong Momentum with Program Awards for MirrorE

NOVI, Mich., May 4, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) will webcast its first quarter

NOVI, Mich., April 28, 2026 /PRNewswire/ -- Driven by accelerating global demand for advanced vision

Stoneridge (NYSE:SRI) reported quarterly losses of $(0.53) per share which missed the analyst consen

NOVI, Mich., Feb. 2, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE:SRI) today announced that Chief Fin

Stoneridge, Inc. (NYSE:SRI) today announced that it has completed the sale of its Control Devices se

Stoneridge (NYSE:SRI) narrows FY2025 sales outlook from $860.000 million-$890.000 million to $860.00

Stoneridge (NYSE:SRI) reported quarterly losses of $(0.18) per share which missed the analyst consen

Barrington Research analyst Gary Prestopino maintains Stoneridge (NYSE:SRI) with a Outperform and

Two auto stocks are seeing their strength fade over the past week, with their Momentum scores in Ben

Barrington Research analyst Gary Prestopino maintains Stoneridge (NYSE:SRI) with a Outperform and

Stoneridge (NYSE:SRI) reported quarterly losses of $(0.25) per share which missed the analyst consen

Barrington Research analyst Gary Prestopino maintains Stoneridge (NYSE:SRI) with a Outperform and

Barrington Research analyst Gary Prestopino maintains Stoneridge (NYSE:SRI) with a Outperform and

Barrington Research analyst Gary Prestopino maintains Stoneridge (NYSE:SRI) with a Outperform and

Barrington Research analyst Gary Prestopino maintains Stoneridge (NYSE:SRI) with a Outperform and

2025 and Future OutlookThe Company is maintaining its guidance ranges for its full-year 2025 perform

Stoneridge (NYSE:SRI) reported quarterly losses of $(0.19) per share which missed the analyst consen